Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine
Doh-Ura, K; Tamura, K; Karube, Y; Naito, M; Tsuruo, T; Kataoka, Y
HERO ID
1490827
Reference Type
Journal Article
Year
2007
Language
English
PMID
| HERO ID | 1490827 |
|---|---|
| In Press | No |
| Year | 2007 |
| Title | Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine |
| Authors | Doh-Ura, K; Tamura, K; Karube, Y; Naito, M; Tsuruo, T; Kataoka, Y |
| Journal | Cellular and Molecular Neurobiology |
| Volume | 27 |
| Issue | 3 |
| Page Numbers | 303-316 |
| Abstract | 1. As an extension of our previous study of quinacrine and its derivatives, chelating chemicals were screened to obtain more effective, better brain-permeable antiprion compounds using either prion-infected neuroblastoma cells or brain capillary endothelial cells. 2. Eleven chemicals were found to have antiprion activity. Most of them shared a common structure consisting of benzene or naphthalene at either end of an azo bond. Structure-activity data suggest that chelating activity is not necessary but might contribute to the antiprion action. 3. Chrysoidine, a representative compound found here, was about 27 times more effective in the antiprion activity and five times more efficiently permeable through the brain capillary endothelial cells than quinacrine was. 4. These chemicals might be useful as compounds for development of therapeutics for prion diseases. |
| Doi | 10.1007/s10571-006-9122-0 |
| Pmid | 17235694 |
| Wosid | WOS:000246562100004 |
| Url | https://www.scopus.com/inward/record.uri?eid=2-s2.0-34248512609&doi=10.1007%2fs10571-006-9122-0&partnerID=40&md5=e1f1c36ff4093132792d8f28611cd8a1 |
| Is Certified Translation | No |
| Dupe Override | No |
| Comments | Source: Web of Science WOS:000246562100004 |
| Is Public | Yes |
| Language Text | English |
| Keyword | prion; chrysoidine; blood-brain barrier; aromatic azo compounds; therapy; chelating agents; brain endothelial cells; prion-infected neuroblastoma cells |